Company Filing History:
Years Active: 2002-2005
Title: Innovations of John C McMichael
Introduction
John C McMichael is a notable inventor based in Rochester, NY (US). He has made significant contributions to the field of biotechnology, particularly in the development of vaccine compositions. With a total of two patents to his name, McMichael's work has the potential to impact public health positively.
Latest Patents
One of McMichael's latest patents involves the isolation and purification of a 74-kilodalton outer membrane protein from Moraxella catarrhalis. This protein, designated as the 74 kD protein, has an amino-terminal amino acid sequence that is conserved among various strains. The protein has a molecular weight of approximately 74.9 kD as measured on a 10% SDS-PAGE gel, while its molecular weight as measured by mass spectrometry is approximately 74 kD. The 74 kD protein is utilized to prepare a vaccine composition that elicits a protective immune response in a mammalian host, aimed at protecting against diseases caused by Moraxella catarrhalis.
Career Highlights
Throughout his career, McMichael has worked with prominent companies such as American Cyanamid Company and Wyeth Holdings Corporation. His experience in these organizations has contributed to his expertise in the field of vaccine development and biotechnology.
Collaborations
Some of McMichael's notable coworkers include Dexiang Chen and Karl R VanDerMeid. Their collaborative efforts have likely enhanced the research and development processes in which they were involved.
Conclusion
John C McMichael's contributions to the field of biotechnology, particularly through his patents, demonstrate his commitment to advancing public health. His work on the 74 kD protein showcases the potential for innovative vaccine development.